Matches in SemOpenAlex for { <https://semopenalex.org/work/W3022682132> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W3022682132 abstract "Background Visceral Leishmaniasis is a macrophage-associated disorder for the treatment of which antimony based drug like Sodium Antimony Gluconate has been the first choice in the recent past. About 5 percent of the patients may develop insulin dependent diabetes mellitus. It appears to have a direct action on pancreatic beta cells, resulting in initial insulin release followed by impaired insulin secretion. Within this context, we looked into alternative therapies of treatment along with SAG on triggering the CD2 epitope. Methods We have evaluated the effect of combining CD2 with conventional antimonial (sb) therapy in protection in BALB/c mice infected with either drug sensitive or resistant strain of Leishmania donovani with 3 million parasites via-intra-cardiac route. Mice were treated with anti CD2 adjunct SAG sub-cutaneously twice a week for 4 weeks. Assessment for measurement of weight, spleen size, anti-Leishmania antibody titer, T cell and anti-leishmanial macrophage function was carried out day 0, 10, 22 and 34 post treatments. Insulin levels were also determined on the same intervals. Results The combination therapy was shown boosting significant proportion of T cells to express CD25 compared to SAG monotherapy. Although, the level of IFN-γ was not statistically different between combination vs monotherapy (p = 0.298) but CD2 treatment even alone significantly influenced IFN- γ production than either SAG treatment (p = 0.045) or with CD2 adjunct SAG treatment (p = 0.005) in Ld-S strain as well as in Ld-R strain. The influence of CD2 adjunct treatment was also documented in anti-leishmanial functions in macrophages. Interestingly insulin levels were observed to be optimal on supplementing SAG along with CD2. Conclusions SAG along with CD2 could be used as a potential therapy to overcome incidences of Diabetes mellitus during Visceral Leishmaniasis" @default.
- W3022682132 created "2020-05-13" @default.
- W3022682132 creator A5027344819 @default.
- W3022682132 date "2019-06-01" @default.
- W3022682132 modified "2023-09-23" @default.
- W3022682132 title "IDDF2019-ABS-0177 Modulation of antimony mediated therapy for an optimal insulin secretion during visceral leishmaniasis" @default.
- W3022682132 doi "https://doi.org/10.1136/gutjnl-2019-iddfabstracts.183" @default.
- W3022682132 hasPublicationYear "2019" @default.
- W3022682132 type Work @default.
- W3022682132 sameAs 3022682132 @default.
- W3022682132 citedByCount "0" @default.
- W3022682132 crossrefType "proceedings-article" @default.
- W3022682132 hasAuthorship W3022682132A5027344819 @default.
- W3022682132 hasBestOaLocation W30226821321 @default.
- W3022682132 hasConcept C126322002 @default.
- W3022682132 hasConcept C134018914 @default.
- W3022682132 hasConcept C151730666 @default.
- W3022682132 hasConcept C203014093 @default.
- W3022682132 hasConcept C2776555147 @default.
- W3022682132 hasConcept C2776999253 @default.
- W3022682132 hasConcept C2778689377 @default.
- W3022682132 hasConcept C2779306644 @default.
- W3022682132 hasConcept C2779343474 @default.
- W3022682132 hasConcept C2780122544 @default.
- W3022682132 hasConcept C2780931953 @default.
- W3022682132 hasConcept C2781333301 @default.
- W3022682132 hasConcept C71924100 @default.
- W3022682132 hasConcept C86803240 @default.
- W3022682132 hasConcept C90924648 @default.
- W3022682132 hasConcept C98274493 @default.
- W3022682132 hasConceptScore W3022682132C126322002 @default.
- W3022682132 hasConceptScore W3022682132C134018914 @default.
- W3022682132 hasConceptScore W3022682132C151730666 @default.
- W3022682132 hasConceptScore W3022682132C203014093 @default.
- W3022682132 hasConceptScore W3022682132C2776555147 @default.
- W3022682132 hasConceptScore W3022682132C2776999253 @default.
- W3022682132 hasConceptScore W3022682132C2778689377 @default.
- W3022682132 hasConceptScore W3022682132C2779306644 @default.
- W3022682132 hasConceptScore W3022682132C2779343474 @default.
- W3022682132 hasConceptScore W3022682132C2780122544 @default.
- W3022682132 hasConceptScore W3022682132C2780931953 @default.
- W3022682132 hasConceptScore W3022682132C2781333301 @default.
- W3022682132 hasConceptScore W3022682132C71924100 @default.
- W3022682132 hasConceptScore W3022682132C86803240 @default.
- W3022682132 hasConceptScore W3022682132C90924648 @default.
- W3022682132 hasConceptScore W3022682132C98274493 @default.
- W3022682132 hasLocation W30226821321 @default.
- W3022682132 hasOpenAccess W3022682132 @default.
- W3022682132 hasPrimaryLocation W30226821321 @default.
- W3022682132 hasRelatedWork W147336870 @default.
- W3022682132 hasRelatedWork W1565950110 @default.
- W3022682132 hasRelatedWork W2036042598 @default.
- W3022682132 hasRelatedWork W2038588727 @default.
- W3022682132 hasRelatedWork W2046702850 @default.
- W3022682132 hasRelatedWork W2067547048 @default.
- W3022682132 hasRelatedWork W2078060782 @default.
- W3022682132 hasRelatedWork W2082029206 @default.
- W3022682132 hasRelatedWork W2107837002 @default.
- W3022682132 hasRelatedWork W2135813534 @default.
- W3022682132 hasRelatedWork W2166902572 @default.
- W3022682132 hasRelatedWork W2356291247 @default.
- W3022682132 hasRelatedWork W2408232657 @default.
- W3022682132 hasRelatedWork W2410137325 @default.
- W3022682132 hasRelatedWork W2415157517 @default.
- W3022682132 hasRelatedWork W2807073140 @default.
- W3022682132 hasRelatedWork W288688715 @default.
- W3022682132 hasRelatedWork W3048458574 @default.
- W3022682132 hasRelatedWork W904696527 @default.
- W3022682132 hasRelatedWork W948487646 @default.
- W3022682132 isParatext "false" @default.
- W3022682132 isRetracted "false" @default.
- W3022682132 magId "3022682132" @default.
- W3022682132 workType "article" @default.